Qelbree (Viloxazine): A Non-Stimulant Option for ADHD

Not everyone with ADHD can or wants to take stimulant medications. At Next Step Psychiatry in Lilburn, we offer various treatment options including Qelbree—a newer non-stimulant medication approved for ADHD in children, adolescents, and adults.

What Is Qelbree?

Qelbree (viloxazine) is a selective norepinephrine reuptake inhibitor (SNRI) that increases norepinephrine availability in the brain, helping manage ADHD symptoms without the potential for abuse associated with stimulants.

Who Might Consider Qelbree?

• Those who haven't responded well to stimulants
• People concerned about stimulant side effects or abuse potential
• Patients with conditions that contraindicate stimulants
• Those who prefer non-controlled medication

Dosing

• Children 6-11: Starting dose 100mg/day, max 400mg/day
• Adolescents 12-17: Starting dose 200mg/day, max 400mg/day
• Adults: Starting dose 200mg/day, max 600mg/day

Common Side Effects

• Drowsiness (often improves over time)
• Decreased appetite
• Nausea
• Headache
• Insomnia
• Fatigue

Benefits vs. Stimulants

• No "crash" when medication wears off
• Not a controlled substance—no abuse potential
• Can be an option when stimulants aren't appropriate